Oramed Pharmaceuticals (ORMP) Current Leases (2019 - 2026)
Oramed Pharmaceuticals (ORMP) posted Current Leases of $268000.0 for Q1 2026, down 5.96% on a QoQ basis from $285000.0 in Q4 2025, and up 48.07% year-over-year from $181000.0 in Q1 2025.
Oramed Pharmaceuticals (ORMP) Current Leases (2019 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Current Leases history runs 8 years deep, the most recent figure standing at $268000.0 for Q1 2026.
- Quarterly Current Leases rose 48.07% year-over-year to $268000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $268000.0 (up 48.07% YoY) and the FY2025 annual result came in at $285000.0, up 31.94% from the prior year.
- Current Leases was $268000.0 for Q1 2026 at Oramed Pharmaceuticals, down from $285000.0 in the prior quarter.
- Across five years, Current Leases topped out at $285000.0 in Q4 2025 and bottomed at $181000.0 in Q1 2025.
- A 5-year average of $245470.6 and a median of $247000.0 in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2025 — Current Leases fell 28.74% — and 2026, when it surged 48.07%.
- Oramed Pharmaceuticals' Current Leases stood at $247000.0 in 2022, then rose by 8.1% to $267000.0 in 2023, then declined by 19.1% to $216000.0 in 2024, then jumped by 31.94% to $285000.0 in 2025, then decreased by 5.96% to $268000.0 in 2026.
- Business Quant data shows ORMP's Current Leases at $268000.0 in Q1 2026, $285000.0 in Q4 2025, and $271000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 473.74 Bn | 468.95 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 122.07 Bn | 114.82 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.24 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Oramed Pharmaceuticals | 168.80 Mn | 168.80 Mn | - | 268,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 268,000.00 |
| Dec 31, 2025 | 285,000.00 |
| Sep 30, 2025 | 271,000.00 |
| Jun 30, 2025 | 264,000.00 |
| Mar 31, 2025 | 181,000.00 |
| Dec 31, 2024 | 216,000.00 |
| Sep 30, 2024 | 243,000.00 |
| Jun 30, 2024 | 250,000.00 |
| Mar 31, 2024 | 254,000.00 |
| Dec 31, 2023 | 267,000.00 |
| Sep 30, 2023 | 251,000.00 |
| Jun 30, 2023 | 236,000.00 |
| Mar 31, 2023 | 242,000.00 |
| Dec 31, 2022 | 247,000.00 |
| Sep 30, 2022 | 228,000.00 |
| Jun 30, 2022 | 233,000.00 |
| Mar 31, 2022 | 237,000.00 |
| Nov 30, 2021 | 130,000.00 |
| Aug 31, 2021 | 130,000.00 |
| May 31, 2021 | 129,000.00 |